Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Jul 17, 2023 424B5
8-K Jul 17, 2023 8-K
8-K Jul 17, 2023 8-K
4 Jun 13, 2023 OWNERSHIP DOCUMENT
8-K Jun 8, 2023 8-K
4 Jun 7, 2023 FORM 4
4 Jun 7, 2023 FORM 4
4 Jun 7, 2023 FORM 4
4 Jun 7, 2023 FORM 4
4 Jun 7, 2023 FORM 4
4 Jun 7, 2023 FORM 4
10-Q May 9, 2023 10-Q
8-K May 9, 2023 8-K
DEFA14A Apr 28, 2023 DEFA14A
ARS Apr 27, 2023 ARS
DEF 14A Apr 27, 2023 DEF 14A
424B5 Apr 27, 2023 424B5
8-K Apr 27, 2023 8-K
PRE 14A Apr 14, 2023 PRE 14A
S-8 Mar 28, 2023 S-8
10-K Mar 27, 2023 10-K
8-K Mar 27, 2023 8-K
8-K Mar 15, 2023 8-K
SC 13G/A Feb 14, 2023 AMENDMENT TO FORM SC 13G
SC 13G/A Feb 14, 2023
← Newer Page 10 of 15 · 365 filings Older →